4.1 Article

Multiple sclerosis and pregnancy

Journal

REVUE NEUROLOGIQUE
Volume 170, Issue 4, Pages 247-265

Publisher

MASSON EDITEUR
DOI: 10.1016/j.neurol.2013.09.010

Keywords

Multiple sclerosis; Pregnancy; Delivery; Epidural analgesia; Breastfeeding; Clinical practice guidelines; Rand Ucla appropriateness method

Funding

  1. Novartis
  2. Biogen-Idec
  3. Teva Pharma
  4. Genzyme Sanofi-Aventis
  5. Merck-Serono
  6. Roche
  7. Bayer
  8. Teva
  9. LFB
  10. Allergan and Almirall Laboratories
  11. BIOGEN-Idec France

Ask authors/readers for more resources

The question of pregnancy in patients with multiple sclerosis is regularly raised due to the prevalence of the disease in middle age women. The multiple sclerosis think tank (Groupe de Reflexion sur la Sclerose en Plaques [GRESEP]) decided to develop recommendations on this issue, with consideration to both the impact of multiple sclerosis on pregnancy, and that of pregnancy on the disease. As with topics of previous works, the formal expert consensus method was used. The working group was composed of hospital-based and private practice neurologists. The reading group was composed of neurologists, anaesthetists and obstetricians. Each recommendation is presented with the relevant level of consensus. (C) 2014 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available